Skyline AI Founders
From left: Skyline founders Iri Amirav, Guy Zipori, Amir Leitersdorf and Or Hiltch

Skyline AI investment platform raises $18m in funding

Skyline AI, a platform that uses Artificial Intelligence to connect investors to property opportunities, has raised $18m in a Series A Round, with investment from Sequioa Capital, TLV Partners and JLL Spark.

Powered by natural language processing and high performance data infrastructure, data from more than 130 sources is compiled into one large “data lake,” and then cross-validated to make sure the data used is accurate. This enables Skyline AI to provide a deep assessment and accurate actionable predictions, within seconds, about any asset in the US.

Skyline AI uses its technological advantage to detect and exploit market anomalies, identify superior risk-reward investments, and discover untapped value creation opportunities. The Skyline AI platform also provides continuous market data analysis and information during the entire ownership period.

The Series A round has closed just 4 months after Skyline announced $3m in seed funding. The AI platform’s total funding currently sits at $21m.

Guy Zipori, co-founder and CEO of Skyline AI, commented: “Commercial real estate is coming out of the dark ages when it comes to technology. We developed a platform that injects advanced AI directly into the core of the acquisition and ownership process, leveraging the largest data set in the industry to predict the performance of any asset in the US.”

Yishai Lerner, Co-CEO of JLL Spark, said of the investment: “When we saw what the Skyline AI platform could do, we knew immediately that their technology is going to play a significant role in the commercial real estate investment market.”

Skyline AI was founded by 4 tech entrepreneurs who have previously launched AI-driven startup ventures in industries including security, healthcare and online video. The co-founders are CEO Guy Zipori, CTO Or Hiltch, CRO Iri Amirav and executive chairman Amir Leitersdorf.

Your comments

Read our comments policy here